Paolo Morgese | Vice President, Public Affairs, Europe
Alliance for Regenerative Medicine

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Appearances:



Day 1: 17th March 2026 @ 16:05

Chair’s Remarks: Paolo Morgese VP Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Day 1: 17th March 2026 @ 17:30

Panel Discussion: Perspectives on the EU Joint Health Technology Assessment: Is the JCA fit for purpose?

Moderator: Matias Olsen, Senior Manager, Public Affairs & Policy, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Dilip Patel, SVP, Access & Market Development, Autolus
Henriette Burghoorn, Associate Director, Market Access, Gilead Sciences
Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine
Rosie Lindup, Senior Policy and Public Affairs Manager, BioIndustry Association (BIA)
Brett Doble, Director HEOR, Australia/Canada/Europe (ACE), HEOR Center of Excellence, Kite, a Gilead Company
Patrick Hopkinson, Independent HTA Expert, Independent HTA Expert
last published: 11/Jul/25 11:15 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150